AFFÄRSIDÉ

Immune Pharmaceuticals är marknadsledande inom antikroppsterapi och utvecklar nya, riktade mediciner avsedda att förbättra livet för patienter med inflammatoriska sjukdomar och cancer.

Bransch: Hälsovård
Marknad: First North
Tickerkod: IMNP
Certified Adviser: Erik Penser Bank

WEBBPLATS

OMSÄTTNING OCH AKTIEKURS

I grafen visas aktiekursutveckling och omsättning för valt bolag. Informationen är fördröjd med 15 min.

Omsättning
Aktuell Kurs
Utvecklingen i dag
2012 2013 2014 2015 2016
Nettoomsättning (MSEK) 0 0 0
Rörelseresultat (MSEK) 0 0 0
Årets resultat (MSEK) 0 0 0
Balansomslutning (MSEK) 0 0 0
Eget Kapital (MSEK) 0 0 0
Antal anställda

AKTUELLA NYCKELTAL

Urval av finansiell data för valt bolag.

Pressreleaser | 12 Apr 2017 | Immune Pharmaceuticals

Immune Pharmaceuticals Announces 1-for-…

IMMUNE PHARMACEUTICALS ANNOUNCES 1-FOR-20 REVERSE STOCK SPLIT Immune Pharmaceuticals Inc. (Nasdaq: IMNP) (”Immune” or the ”Company”), today announced a reverse stock split of its shares of common stock at a…

Läs hela nyheten
Pressreleaser | 13 Mar 2017 | Immune Pharmaceuticals

Immune Pharmaceuticals Granted…

IMMUNE PHARMACEUTICALS GRANTED ADDITIONAL TIME TO COMPLY WITH NASDAQ LISTING REQUIREMENT Immune Pharmaceuticals Inc. (Nasdaq: IMNP) (”Immune” or the ”Company”), announced today that following a hearing on March 9, 2017,…

Läs hela nyheten
Pressreleaser | 28 Feb 2017 | Immune Pharmaceuticals

Immune Pharmaceuticals Reports…

IMMUNE PHARMACEUTICALS REPORTS ENCOURAGING PRELIMINARY DATA WITH BERTILIMUMAB IN AN OPEN LABEL PHASE 2 STUDY IN THE RARE DERMATOLOGICAL AUTO-IMMUNE DISEASE, BULLOUS PEMPHIGOID Broadens Eligibility Criteria to Include Steroid Tapering…

Läs hela nyheten
Pressreleaser | 17 Feb 2017 | Immune Pharmaceuticals

Immune Pharmaceuticals Announces the…

IMMUNE PHARMACEUTICALS ANNOUNCES THE LAUNCH OF REMAIN ™ , AN INTERNATIONAL OVERALL SURVIVAL STUDY WITH CEPLENE® AND LOW DOSE PROLEUKIN® IN REMISSION MAINTENANCE IN ACUTE MYELOID LEUKEMIA Ceplene Currently Approved…

Läs hela nyheten
Pressreleaser | 27 Jan 2017 | Immune Pharmaceuticals

Immune Pharmaceuticals Appoints New…

IMMUNE PHARMACEUTICALS APPOINTS NEW CHAIRMAN OF THE BOARD OF DIRECTORS Ranch Kimball to Lead Immune’s Board of Directors Immune Pharmaceuticals Inc. (Nasdaq: IMNP), announced today it has appointed Ranch C.…

Läs hela nyheten
Pressreleaser | 23 Jan 2017 | Immune Pharmaceuticals

Immune Pharmaceuticals Enters a Research…

IMMUNE PHARMACEUTICALS ENTERS A RESEARCH PARTNERSHIP TO DEVELOP MONO- AND BISPECIFIC ANTIBODIES AGAINST NOVEL TARGETS IN THE TUMOR MICROENVIRONMENT Immune Pharmaceuticals Inc. (NASDAQ: IMNP), ”Immune”, a clinical-stage biopharmaceutical company developing…

Läs hela nyheten
Pressreleaser | 17 Jan 2017 | Immune Pharmaceuticals

Immune Pharmaceuticals Satellite…

IMMUNE PHARMACEUTICALS SATELLITE SYMPOSIUM AT THE INTERNATIONAL SYMPOSIUM ON ACUTE LEUKEMIAS XVI ”Reinforcing the Efficacy of Immunotherapy for the maintenance of remission in AML with Ceplene®”, February 20, 2017 Immune…

Läs hela nyheten
Pressreleaser | 10 Jan 2017 | Immune Pharmaceuticals

Immune Pharmaceuticals Will Request an…

IMMUNE PHARMACEUTICALS WILL REQUEST AN APPEAL TO REGAIN COMPLIANCE WITH NASDAQ’S MINIMUM BID PRICE RULE Immune Pharmaceuticals Inc. (Nasdaq: IMNP) (”Immune”), announced today that it intends to request a hearing…

Läs hela nyheten
Pressreleaser | 22 Nov 2016 | Immune Pharmaceuticals

Immune Pharmaceuticals Announces Immuno-…

IMMUNE PHARMACEUTICALS ANNOUNCES IMMUNO-ONCOLOGY R&D UPDATE ON DECEMBER 8, 2016 Confirms plans for pivotal phase 3 Overall Survival study with Ceplene in AML Immune Pharmaceuticals (NASDAQ:IMNP) (Immune) announced today that…

Läs hela nyheten
Pressreleaser | 17 Nov 2016 | Immune Pharmaceuticals

Immune Pharmaceuticals Secures Up to $11…

IMMUNE PHARMACEUTICALS SECURES UP TO $11 MILLION IN NEW FINANCING TO BE DEPLOYED WITH A FOCUS ON BERTILIMUMAB CLINICAL DEVELOPMENT Immune Pharmaceuticals (NASDAQ:IMNP) (Immune) announced today that it has secured…

Läs hela nyheten

ca.penser.se använder cookies för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder cookies. Vad är cookies?

Jag godkänner